AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for the treatment of lung cancer patients across ...

Certain Medicare plans typically cover at least part of the cost of inhalers for COPD. There are also several ways to further save on costs.

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

MRI of inhaled perfluoropropane can assess regional lung ventilation and monitor improvements in response to medication ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

Background Whether inhaled corticosteroids (ICSs ... Second, an important question arising from this research is whether medication response is influenced by demographics or COPD phenotypes.

The U.S. Food and Drug Administration has approved Eli Lilly's Omvoh (mirikizumab-mrkz) for the treatment of moderately to ...

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

“In some cases, they’ll be told to increase their inhalers for a ... then you have got treatment to take quickly to get on top of your symptoms.” “COPD is a condition where there is ...

[39,40,41,42,43,44,45] Significant differences in health beliefs, experiences, and behaviors were observed between COPD patients with high medication adherence and suboptimal adherence. The ...